Lomiko Metals (LMR) Stock Chart & Stock Price History → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free LMR Stock Alerts C$0.02 0.00 (0.00%) (As of 05:22 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartHeadlinesInsider Trades Lomiko Metals Stock Price Performance5 Day Performance-25.00%1 Month Performance0.00%3 Month Performance0.00%6 Month Performance-25.00%Year-To-Date Performance-25.00%1 Year Performance-40.00% Receive LMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lomiko Metals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. LMR Stock Chart for Friday, April, 19, 2024 LMR Chart by TradingView Lomiko Metals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024C$0.02C$0.02C$0.02C$0.0264,000 shsC$6.00 million04/18/2024C$0.02C$0.02C$0.02C$0.02135,069 shsC$6.00 million04/17/2024C$0.02C$0.02C$0.02C$0.01827,015 shsC$6.00 million04/16/2024C$0.02C$0.02C$0.02C$0.02761,400 shsC$6.00 million04/15/2024C$0.02C$0.02-25.00%C$0.02C$0.0294,000 shsC$6.00 million04/12/2024C$0.02C$0.02+33.33%C$0.02C$0.0225,100 shsC$8.00 million Get the Latest News and Ratings for LMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lomiko Metals and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024C$0.02C$0.02-25.00%C$0.02C$0.0231,000 shsC$6.00 million04/10/2024C$0.02C$0.02C$0.02C$0.0265,500 shsC$8.00 million04/09/2024C$0.02C$0.02+33.33%C$0.02C$0.02117,300 shsC$8.00 million04/08/2024C$0.02C$0.02-25.00%C$0.02C$0.02274,500 shsC$6.00 million04/05/2024C$0.02C$0.02+33.33%C$0.02C$0.02109,000 shsC$8.00 million04/04/2024C$0.02C$0.02C$0.02C$0.02205,019 shsC$6.00 million04/03/2024C$0.02C$0.02-25.00%C$0.02C$0.02180,400 shsC$6.00 million04/02/2024C$0.02C$0.02+33.33%C$0.02C$0.0215,450 shsC$8.00 million04/01/2024C$0.02C$0.02C$0.02C$0.02186,337 shsC$6.00 million03/29/2024C$0.02C$0.02C$0.02C$0.01673,399 shsC$6.00 million03/28/2024C$0.02C$0.02C$0.02C$0.01673,399 shsC$6.00 million03/27/2024C$0.02C$0.02C$0.02C$0.0289,000 shsC$6.00 million03/26/2024C$0.02C$0.02C$0.02C$0.01556,400 shsC$6.00 million03/25/2024C$0.02C$0.02C$0.02C$0.01556,400 shsC$6.00 million03/22/2024C$0.02C$0.02C$0.02C$0.02521,000 shsC$6.00 million03/21/2024C$0.02C$0.02C$0.02C$0.022.70 million shsC$6.00 million03/20/2024C$0.02C$0.02C$0.02C$0.02328,000 shsC$6.00 million03/19/2024C$0.02C$0.02C$0.02C$0.02320,500 shsC$6.00 million03/18/2024C$0.02C$0.02C$0.02C$0.02320,500 shsC$6.00 million03/15/2024C$0.02C$0.02C$0.02C$0.02320,500 shsC$6.00 million03/14/2024C$0.02C$0.02-25.00%C$0.02C$0.02320,500 shsC$6.00 million03/13/2024C$0.02C$0.02C$0.02C$0.0217,905 shsC$8.00 million03/12/2024C$0.02C$0.02C$0.02C$0.0245,000 shsC$8.00 million03/11/2024C$0.02C$0.02+33.33%C$0.02C$0.0218,000 shsC$8.00 million03/08/2024C$0.02C$0.02-25.00%C$0.02C$0.02110,000 shsC$6.00 million03/07/2024C$0.02C$0.02C$0.02C$0.026,000 shsC$8.00 million03/06/2024C$0.02C$0.02C$0.02C$0.0222,000 shsC$8.00 million03/05/2024C$0.02C$0.02+33.33%C$0.02C$0.02501,924 shsC$8.00 million03/04/2024C$0.02C$0.02-25.00%C$0.02C$0.022.14 million shsC$6.00 million03/01/2024C$0.02C$0.02+33.33%C$0.02C$0.02137,000 shsC$8.00 million02/29/2024C$0.02C$0.02C$0.02C$0.02524,721 shsC$6.00 million02/28/2024C$0.02C$0.02C$0.02C$0.02139,500 shsC$6.00 million02/27/2024C$0.02C$0.02C$0.02C$0.02189,034 shsC$6.00 million02/26/2024C$0.02C$0.02C$0.02C$0.027,000 shsC$6.00 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/23/2024C$0.02C$0.02C$0.02C$0.0279,000 shsC$6.00 million02/22/2024C$0.02C$0.02C$0.02C$0.021.35 million shsC$6.00 million02/21/2024C$0.02C$0.02C$0.02C$0.02617,000 shsC$6.00 million02/20/2024C$0.02C$0.02C$0.02C$0.02579,500 shsC$6.00 million02/19/2024C$0.02C$0.02C$0.02C$0.02162,348 shsC$6.00 million02/16/2024C$0.02C$0.02-25.00%C$0.02C$0.02162,348 shsC$6.00 million02/15/2024C$0.02C$0.02+33.33%C$0.02C$0.0215,000 shsC$8.00 million02/14/2024C$0.02C$0.02-25.00%C$0.02C$0.0252,900 shsC$6.00 million02/13/2024C$0.02C$0.02C$0.02C$0.02110,000 shsC$8.00 million02/12/2024C$0.02C$0.02C$0.02C$0.02110,000 shsC$8.00 million02/09/2024C$0.02C$0.02+33.33%C$0.02C$0.0218,500 shsC$8.00 million02/08/2024C$0.02C$0.02C$0.02C$0.026,000 shsC$6.00 million02/07/2024C$0.02C$0.02C$0.02C$0.0212,000 shsC$6.00 million02/06/2024C$0.02C$0.02C$0.02C$0.0220,000 shsC$6.00 million02/05/2024C$0.02C$0.02C$0.02C$0.0233,000 shsC$6.00 million02/02/2024C$0.02C$0.02-25.00%C$0.02C$0.02116,006 shsC$6.00 million02/01/2024C$0.02C$0.02+33.33%C$0.02C$0.0257,000 shsC$8.00 million01/31/2024C$0.02C$0.02C$0.02C$0.026,500 shsC$6.00 million01/30/2024C$0.02C$0.02C$0.02C$0.027,000 shsC$6.00 million01/29/2024C$0.02C$0.02C$0.02C$0.022,000 shsC$6.00 million01/26/2024C$0.02C$0.02-25.00%C$0.02C$0.0220,000 shsC$6.00 million01/25/2024C$0.02C$0.02+33.33%C$0.02C$0.0248,000 shsC$8.00 million01/24/2024C$0.02C$0.02C$0.02C$0.0269,000 shsC$6.00 million01/23/2024C$0.02C$0.02C$0.02C$0.0269,000 shsC$6.00 million01/22/2024C$0.02C$0.02C$0.02C$0.0269,000 shsC$6.00 million01/19/2024C$0.02C$0.02C$0.02C$0.0211,000 shsC$6.00 million01/18/2024C$0.02C$0.02-25.00%C$0.02C$0.0211,000 shsC$6.00 million Related Companies: SSE Stock Chart NEV Stock Chart SIE Stock Chart CBI Stock Chart SRI Stock Chart STH Stock Chart KZD Stock Chart ION Stock Chart FEO Stock Chart HUD Stock Chart Receive LMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lomiko Metals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:LMR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lomiko Metals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.